TuHURA Biosciences Inc Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline HWBK Q1 2026 Earnings Strong EPS Performance Amid No Revenue Guidance Scinai Immunotherapeutics SCNI Q4 2023 Earnings NarrowerThanExpected Loss Amid Operational Adjustments MKTW Q1 2026 Earnings Deep EPS Miss Overshadowed by Modest Stock Recovery RILY Q1 2024 Earnings Wide Net Loss Highlights Challenging Market Conditions PATK Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operational Execution